Journals / Yeni Tıp Dergisi / 2010 / Cilt: 27 - Sayı: 2

Proteomics

Proteomik

Pages
70–75
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

We will also review proteomics technology in biomarker discovery, especially early detection of cancer and diagnosis and treatment of some other diseases and population proteomics.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Since information obtained from genomic studies is limited, proteomics, which is an advance of genomics, become more important in the evaluation of the biological events.
📊
Key Findings & Data:Proteomics methodologies require techniques to separate and quantify individual proteins and identify those proteins.
💡
Conclusion & Impact:We will also review proteomics technology in biomarker discovery, especially early detection of cancer and diagnosis and treatment of some other diseases and population proteomics.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Since information obtained from genomic studies is limited, proteomics, which is an advance of genomics, become more important in the evaluation of the biological events. Proteomics is to analyse proteins expressed by genom under certain conditions and in a spesific tissue, that is proteomics is to identify proteom. The main goal of proteomics studies is the understanding of proteins including their identification, characterization, and quantification of proteins in whole cells, tissues, or body fluids. Proteomics methodologies require techniques to separate and quantify individual proteins and identify those proteins. In this article, we review the current proteomics technologies which include two-dimensional gel electrophoresis (2-DE), two-dimensional differential ingel electrophoresis (2D-DIGE), one-and two-dimensional liquid chromatography (1D-LC and 2D-LC), mass spectrometry (MS) and protein microarray technology. We will also review proteomics technology in biomarker discovery, especially early detection of cancer and diagnosis and treatment of some other diseases and population proteomics.

Özet

Genomik çalışmalardan elde edilen bilgiler sınırlı olduğundan, genomiğin devamı olan proteomik biyolojik olayların açıklanmasında önem kazanmıştır. Proteomik belli şartlar altında ve belli bir dokuda genom tarafından kodlanan tüm proteinlerin, yani proteomun analiz edilmesi işlemidir. Proteomik çalışmalarının esas amacı bütün hücre, doku ve vücut sıvılarındaki proteinleri, özellikleri ve seviyelerini de içerecek şekilde belirleyerek tanımlamaktır. Proteomik çalışmaları proteinlerin ayrılması, miktarlarının belirlenmesi ve bu proteinlerin tanımlanması teknolojilerine ihtiyaç duyar. Bu makalede biz iki yönlü jel elektroforezi (2-DE), iki yönlü differential jel elektroforezi (2D-DIGE), tek ve iki yönlü sıvı kromatografisi (1D-LC ve 2D-LC), kütle spektrofotometresi (MS) ve protein mikroarray teknolojileri olan son proteomik teknolojileri üzerinde durduk. Aynı zamanda biyomarker keşfi, özellikle erken kanser tanısı olmak üzere bazı diğer hastalıkların tanı ve tedavisi ile toplumsal proteomik çalışmalarında proteomik teknolojisinin yerini belirlemeye çalıştık.

🔖

Cite This Article

KURBAN, S., MEHMETOĞLU, İ. (2010). Proteomics. Yeni Tıp Dergisi, Cilt: 27 - Sayı: 2, 70–75. https://ajindex.com/articles/338466

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Del Boccio P, Urbani A. Homo sapiens proteomics: clinical perspectives. Ann Ist Super Sanita 2005;41: 479-82
  2. Denizli A. Protein Analizi. BİLİM ve TEKNİK 2007;476: 66-9
  3. Arthur JM. Proteomics. Curr Opin Nephrol Hypertens 2003;12: 423-30
  4. Anderson L, Seilhamer J. A comparision of selected mRNA and protein abundances in human liver. Electrophoresis 1997;18: 533-7
  5. Graham DR, Elliott ST, Van Eyk JE. Broad-based proteomic strategies: a practical guide to proteomics and functional screening. J Physiol 2005;563: 1–9
  6. Guo Y, Fu Z, Van Eyk JE. A proteomic primer for the clinician. Proc Am Thorac Soc 2007;4: 9-17
  7. Chen Y, Guo Z, Wang X, Qiu C. Sample preparation. J Chromatogr A 2008;1184: 191-219
  8. Von Eggeling F, Gawriljuk A, Fiedler W, Ernst G, Blaussen U, Klose J, et al. Fluorescent dual colour 2D-protein gel electrophoresis for rapid detection of differences in protein patter with standard image analysis software. Int J Mol Med 2001;8: 373–7 9. Tonge R, Shaw J, Middleton B, Rowlinson R, Rayner S, Young J, et al. Validation and development of fluorescence two-dimensional differential gel electrophoresis proteomics techonology. Proteomics 2001;1: 377-96
  9. Neverova I, Van Eyk JE. Role of chromatographic techniques in proteomic analysis. J Chromatogr B Analyt Technol Biomed Life Sci 2005; 815: 51–63
  10. Sheng S, Chen D, Van Eyk JE. Multidimensional liquid chromatography separation of intact proteins by chromatographic focusing and reversed phase of the human serum proteome: optimization and protein database. Mol Cell Proteomics 2006;5: 26-34
  11. Hilario M, Kalousis A, Pellegrini C, Müller M. Processing and classification of protein mass spectra. Mass Spectrom Rev 2006;25: 409-49
  12. Nedelkov D, Kiernan UA, Niederkofler EE, Tubbs KA, Nelson RW. Population proteomics: the concept, attributes, and potential for cancer biomarker research. Mol Cell Proteomics 2006;5: 1811-18
  13. Tang N, Tornatore P, Weinberger SR. Current developments in SELDI affinity technology. Mass Spectrom Rev 2004;23: 34–44
  14. Kallweit U, Börnsen OK, Kresbach GM, Widmer HM. Matrix compatible buffers for analysis of proteins with matrix-assisted laser desorption/ionization mass spectrometry. Rapid Commun Mass Spectrom 1996;10: 845-9
  15. Hall DA, Ptacek J, Snyder M. Protein microarray technology. Mech Ageing Dev 2007;128: 161-7
  16. Han MH, Hwang SI, Roy DB, Lundgren DH, Price JV, Ousman SS, et al. Proteomic analysis of active multiple sclerosis lesions reveals thera